1. Home
  2. FEED vs DSS Comparison

FEED vs DSS Comparison

Compare FEED & DSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FEED

ENvue Medical Inc. Common Stock

N/A

Current Price

$0.92

Market Cap

5.6M

Sector

N/A

ML Signal

N/A

DSS

DSS Inc.

HOLD

Current Price

$0.49

Market Cap

5.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEED
DSS
Founded
2003
1984
Country
United States
United States
Employees
14
N/A
Industry
Containers/Packaging
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.6M
5.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FEED
DSS
Price
$0.92
$0.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
414.6K
38.0K
Earning Date
04-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
42.45
EPS
N/A
N/A
Revenue
N/A
$2,085,000.00
Revenue This Year
N/A
$1.21
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$0.49
52 Week High
$6.09
$1.90

Technical Indicators

Market Signals
Indicator
FEED
DSS
Relative Strength Index (RSI) 32.67 36.62
Support Level $0.84 N/A
Resistance Level $1.54 $1.03
Average True Range (ATR) 0.11 0.03
MACD 0.00 0.01
Stochastic Oscillator 12.76 21.54

Price Performance

Historical Comparison
FEED
DSS

About FEED ENvue Medical Inc. Common Stock

ENvue Medical Inc develops medical devices for enhanced navigation in clinical procedures. The company provides personalized navigation technology to assist clinicians in placing feeding tubes safely and efficiently. Its ENvue system uses smart feeding tubes with sensors, body mapping, and continuous visual guidance to confirm accurate positioning and reduce complications like lung misplacement. The company conducted the business through two primary operating segments: NanoVibronix and ENvue. The firm generates the majority of its revenue from NanoVibronix, which derives revenues from selling its products directly to patients as well as through distributor agreements. ENvue derives revenues from selling its Systems and Nasoenteral tubes.

About DSS DSS Inc.

DSS Inc is operating a business focused on four operating segments: Product Packaging, Biotechnology, Commercial Lending, and Securities and Investment Management. Currently operates five distinct business lines that operate around the globe with primary operations in North America and Asia. Product packaging manufactures and sells sophisticated custom folding cartons, mailers, photo sleeves, and complex three-dimensional direct mail solutions. The biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the Securities and Investment Management.

Share on Social Networks: